Billions of dollars have gone toward finding a single "driver" of aging—a lone gene, a protein, or some specific metabolite. But what if we're looking at an emergent impedance mismatch instead?

Think of your cellular metabolism as a high-frequency signal trying to move through a stiffened, low-frequency medium. In a young body, tissues are viscoelastic enough to allow for seamless signal transduction. The "chassis" and the "engine" hum at the same frequency, and information flows bi-directionally without any lag.

Over time, though, non-enzymatic cross-linking of the ECM—the "Steel Scaffold"—alters the physical resistance of the entire system. We keep trying to fix the engine with NAD+ or rapamycin, but the engine isn't the primary failure point. The signal just can't reach the wheels because the transmission has turned to glass.

Aging is the emergent friction that happens when fast-turnover components like proteins and RNA lose their ability to synchronize with slow-turnover components like collagen and elastin. It isn't just "damage." It's a structural desynchronization.

This explains why a rejuvenation factor can work perfectly in a petri dish but fail in a 70-year-old organism. The mechanical environment acts as a low-pass filter, stripping the "youthful" information out of the signal before it ever hits the nucleus. We’re essentially trying to play a high-definition video through a dial-up modem and wondering why the image is pixelated.

We need to move past the cell-centric view and stop exclusively funding "miracle molecules" that only target high-turnover pathways. We need to fund structural resonance research and learn how to re-tune the mechanical impedance of the interstitial space.

If we don't address the physical coherence of the system, we’re just yelling into a room that’s been soundproofed against us. I’m looking for collaborators focused on the non-enzymatic glycation of the deep scaffold. That’s where the signal is being buried. If we can't clear the filter, the medicine won't matter.